Rupa Cornell was Appointed as Deputy General Counsel and Head of Compliance at Stealth BioTherapeutics

Date of management change: October 17, 2019 

What Happened?

Newton, MA-based Stealth BioTherapeutics Appointed Rupa Cornell as Deputy General Counsel and Head of Compliance


About the Company

Stealth BioTherapeutics is a privately held biopharmaceutical company committed to bringing mitochondria therapies to patients to treat both common and rare diseases. As a key common element in a variety of serious, debilitating diseases, mitochondria – the cell’s energy source – offer a promising, and yet untapped target to modify diseases with significant unmet treatment needs. Stealth is expanding its clinical development program to additional therapeutic areas, including cardio-renal diseases, ophthalmic disorders and orphan mitochondrial diseases. By defining the broad potential of its mitochondrial platform and therapies, Stealth is leading mitochondrial medicine.


About the Person

Rupa Cornell is VP, Head Counsel for Vaccines Business Unit at Takeda. Previously, Rupa held various senior legal leadership roles in the industry.


Info Source



Other IT executives who recently changed jobs as well: Stanley Sofia, Whatley Mike, Park Eunice, Geraigery Tanisha, Dessner Alicia, Bertram Scott, Matz Gary, Zucker Jody, Tahiri Sheryll, Germana Sam, Dahlstrom John

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.